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This patient is a 47-year-old female with a history of end-stage 
liver disease secondary to hepatitis C virus (HCV) complicated 
by hepatic encephalopathy, obstructive sleep apnea, asthma, 
and severe peripheral neuropathy who presents to the hospital 
with complaints of shortness of breath and cough. The patient 
was recently discharged from an outside hospital 2 days prior 
to this admission where she was treated for pneumonia and an 
asthma exacerbation but her symptoms have not improved. She 
complains of shortness of breath at rest and severely decreased 
exercise tolerance with dyspnea while walking across the room. 
Her cough is persistent and non-productive. Review of systems 
is also positive for fevers at the outside hospital and worsening 
peripheral neuropathy which has not responded to treatment with 
gabapentin. Social history is positive for 20 pack-year smoking 
history (quit 10 years ago), and heavy alcohol use in the past.
On presentation to the hospital the patient was dyspneic and 
in moderate respiratory distress. She was afebrile and hypoxic 
to 91% on 2 liters of oxygen via nasal cannula. She had coarse 
breath sounds and wheezing throughout her lung fields, 
significant abdominal distension, and 2 + lower extremity 
pitting edema bilaterally. Initial chest x-ray revealed bilateral 
patchy airspace opacities and low lung volumes. Admission labs 
were within normal limits. 
Hospital Course
The initial differential diagnosis included influenza, pneumonia, 
congestive heart failure exacerbation, interstitial lung disease, 
COPD or asthma exacerbation, and hepatopulmonary 
syndrome. On admission, the patient was empirically treated for 
health care acquired pneumonia with broad spectrum antibiotics 
as well as steroids and nebulizer treatments for asthma/COPD 
exacerbation. Echocardiogram showed normal left and right 
ventricular function without significant valve abnormalities or 
intrapulmonary shunting. Shortly after admission the patient’s 
oxygen needs increased and she became lethargic requiring 
transfer to the intensive care unit and initiation of high flow 
nasal cannula to maintain her oxygen saturation. On hospital 
day # 3 the patient’s respiratory PCR came back positive 
for H1N1; however, a chest CT obtained on hospital day #4 
revealed airspace disease worse than expected from influenza 
alone (Figure 1), and she underwent bronchoscopy with 
transbronchial biopsies on hospital day #5; pathology reports 
revealed interstitial pneumonitis (Figure 2). Subsequent lab 
work, including 9% cryocit and decreased complement levels, 
supported the diagnosis of cryoglobulinemia with pulmonary 
involvement. Patient underwent treatment with plasmapheresis 
and high dose steroids with temporary improvement. However, 
she subsequently required intubation for worsening respiratory 
distress. Since the patient’s underlying HCV had been refractory 
to treatment in the past, the decision was made to withdraw care 
at this point. 
Discussion
Cryoglobulins are single or mixed immunoglobulins that 
undergo reversible precipitation at low temperatures (<37°).5 
Cryoglobulinemia is the presence of these immunoglobulins 
in the serum which results in a clinical syndrome characterized 
by systemic inflammation. Cryoglobulins are divided into 3 
types via the Broucet classification system. Type 1 consists of 
single monoclonal gammaglobulins and is most commonly 
found in patients with lymphoproliferative disorders such as 
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Figure 1. CT scan showing bilateral infiltrative disease
Figure 2. Lung tissue from transbronchial biopsy showing 
interstitial pneumonitits
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multiple myeloma and Waldenstrom’s macroglobulinemia. 
Types 2 and 3 (the mixed cryoglobulinemias) consist of 
polyclonal IgG in complexes with either monoclonal IgM RF 
or polyclonal IgM RF, respectively.1 Mixed cryoglobulinemia 
presents as systemic leukocytic vasculitis of small and 
medium sized vessels with multi-organ involvement.6 Mixed 
cryoglobulinemias are often associated with underlying 
infectious diseases, autoimmune and inflammatory disorders, 
and malignancy. The most commonly associated disease is 
HCV with almost 90% of patients with mixed cryoglobu-
linemia being infected.2 Other associated diseases include 
hepatitis B virus (HBV), lupus, rheumatoid arthritis, and 
Sjogren’s syndrome.1
Cryoglobulinemia is diagnosed by a combination of laboratory, 
pathologic, and clinical findings. Major laboratory criteria 
include a cryocit (percent of precipitating cryoglobulins in the 
serum) >2% and low C4. Minor criteria include the presence 
of rheumatoid factor, HCV and HBV. The major pathologic 
criterion is a finding of leukocytoclastic vasculitis and the 
minor criterion is the presence of clonal b-cell infiltrates under 
light microscopy. Clinical findings include purpura, chronic 
hepatitis, and signs of systemic vasculitis.5 
HCV results in cryoglobulinemic vasculitis through the 
polyclonal activation of B cells resulting in the production of 
autoantibodies including rheumatoid factor and cryoprecip-
itable immune complexes. These complexes are then deposited 
on endothelial surfaces of the affected vessels leading to 
systemic vasculitis.2 Low levels of circulating cryoglobulins are 
found in approximately 50% of patients with HCV but only a 
small number of patients actually develop symptoms. Risks for 
the development of cryoglobulinemia in the setting of HCV 
infection include age, cirrhosis, and the absence of immuno-
suppression.7 
The syndrome of mixed cryoglobulinemia is characterized 
clinically by purpura, weakness, and arthralgias; and by a series 
of pathological conditions representing end organ damage by 
the precipitating cryoglobulins. These include membranopro-
liferative glomerulonephritis, alveolitis, peripheral neuropathy, 
skin ulcers, Raynaud’s phenomenon, and less frequently, 
lymphatic and hepatic malignancies.6 
Respiratory symptoms of cough, dyspnea, and pleuritic pain 
are reported in 40-50% of patients with cryoglobulinemia. The 
findings of pulmonary vasculitis and interstitial infiltrates, 
as seen in our patient, have only been demonstrated in case 
reports. Three cases of patients with chronic HCV published 
in CHEST in October, 2001 are summarized here. The first is 
a 45-year-old female who presented with shortness of breath 
leading to respiratory failure and mechanical ventilation. 
Her bronchoscopy demonstrated alveolar hemorrhage and 
pathology showed diffuse interstitial infiltrates composed 
of lymphocytes. She improved with plasmapheresis. The 
second patient is a 42 -year-old female who presented with 
progressive weakness and sensory loss of her upper and 
lower extremities consistent with peripheral neuropathy. 
She subsequently developed respiratory failure requiring 
mechanical ventilation. Pathology from her bronchoscopy 
also demonstrated lymphocytic alveolitis with diffuse alveolar 
damage. She improved with plasmapheresis. The third patient 
is a 54-year-old male who presented with cough and dyspnea. 
Pathology demonstrated diffuse pneumonitis with prominent 
interstitial lymphocytes. He improved with supportive care. All 
three patients had bilateral patchy ground glass opacities on 
chest CT and an elevated cryocit as were seen in our patient.2 
The mainstay of treatment for the cryoglobulinemic syndrome 
in most patients is to address the underlying HCV, usually with 
interferon and an antiviral such as ribavirin. Other treatments 
include immunosuppression with steroids or oral cyclophos-
phamide, as well as plasma exchange to remove the circulating 
cryoglobulins.5 Evidence shows that cryoglobulinemia should 
be treated with antivirals even if no other indication for treating 
HCV exists.6 One study looking at the effectiveness of treating 
mixed cryoglobulinemia with interferon reported a response 
rate of approximately 70% which correlates with normalization 
of ALT and decreased RNA HCV titers. However, sustained 
response, defined as maintaining undetectable cryoglobulin 
levels at 6 months, only occurred in 14% of patients. Good 
response to interferon is associated with male sex, lower viral 
load, and favorable genotype. Lack of sustained response, 
especially with severe end organ manifestations of cryoglobu-
linemia, may ultimately be secondary to a higher HCV viral 
load.4 It is important to note that even if a patient is having 
improvement in their laboratory values there may not be any 
appreciable symptomatic improvement. One hypothesis for 
this is that the virus forms complexes with the cryoglobulins. 
So even when treatment seems to be leading to decreased ALT 
and circulating HCV RNA there is still a large amount of virus 
contained in the cryoglobulin complexes.6 
Conclusion
Pulmonary involvement secondary to cryoglobulinemia is 
rarely on the differential of a patient presenting with cough 
and respiratory distress. However, the increasing prevalence 
of HCV makes the recognition of mixed cryoglobulinemia 
and its sequelae more important. A better understanding of 
the pulmonary manifestations of cryoglobulinemia, such as 
were seen in our patient, may lead to earlier identification and 
treatment of patients with this disease. 
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